Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 10/20 | 0.70 |
| ▸ | MMP2 | P08253 | 9/20 | 0.70 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 3/20 | 0.51 |
| ▸ | MMP3 | P08254 | 2/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | HPN | P05981 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232590 | 1.00 | MMP9 (0.70) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL14059216 | 0.99 | MMP9 (0.68) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL28895937 | 0.99 | MMP9 (0.68) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL8322406 | 0.96 | MMP9 (0.71) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL10585071 | 0.95 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL457772 | 0.95 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL8001084 | 0.95 | MMP9 (0.76) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| Hydrochloric Acid SCHEMBL9087107 | 0.94 | MMP9 (0.74) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL158952 | 0.91 | MMP9 (0.70) | MMP9MMP2ITGB3ITGA2BTDP1 | |
| SCHEMBL158951 | 0.91 | MMP9 (0.70) | MMP9MMP2ITGB3ITGA2BTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307505-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2019-06-04 | — | — | US | claimed |
| US-20170333592-A1 | Wound Dressings For The Controlled Release Of Therapeutic Agents | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2017-11-23 | — | — | US | claimed |
| US-9687581-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2017-06-27 | — | — | US | claimed |
| CN-105044335-B | Immunochromatographic test strip for rapid detection of ancylostomiasis infection and preparation method thereof | 中国疾病预防控制中心寄生虫病预防控制所 | 2017-01-25 | — | — | CN | claimed |
| CN-105044335-A | Immunochromatographic test strip for rapid detection of ancylostomiasis infection and preparation method thereof | NAT INST OF PARASITIC DISEASES CHINESE CT FOR DISEASE CONTROL AND PREVENTION | 2015-11-11 | — | — | CN | claimed |
| US-20150098985-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC | KCI USA, INC. | 2015-04-09 | — | — | US | claimed |
| EP-1687039-B1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON INC (US) | 2009-01-28 | — | — | EP | claimed |
| EP-0720657-B1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-15 | — | — | EP | claimed |
| US-20070148214-A1 | Wound dressing for the controlled release of therapeutic agents | KCI USA, INC. | 2007-06-28 | — | — | US | claimed |
| EP-1687039-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2006-08-09 | — | — | EP | claimed |
| WO-2005051441-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2005-06-09 | — | — | WO | claimed |
| CN-117858728-A | Chelating compounds for the treatment of substance use disorders and uses thereof | 可利尔科学公司 | 2024-04-09 | — | — | CN | disclosed |
| EP-4135660-A1 | COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUS | Atossa Therapeutics, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021211808-A1 | COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUS | ATOSSA THERAPEUTICS, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| US-20200221753-A1 | TEXTURED INGESTIBLE PRODUCTS | EETBE INC (US) | 2020-07-16 | — | — | US | disclosed |
| CN-1352682-A | Cysteine protease and inhibitors for the prevention and treatment of neurocysticercosis | UNIV GEORGIA RESAERCH FOUNDATI (US) | 2002-06-05 | — | — | CN | disclosed |
| US-20020058288-A1 | Compound for use in the detection and prevention of parasitic infection of humans | AKZO NOBEL N.V. (NL) | 2002-05-16 | — | — | US | disclosed |
| EP-0720657-A1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | NORTH AMERICAN SCIENCE ASSOCIATES INCORPORATED (US) | 1996-07-10 | — | — | EP | disclosed |
| US-5486459-A | Biologically relevant methods for the rapid determination of sterility | MEDICAL COLLEGE OF OHIO (US) | 1996-01-23 | — | — | US | disclosed |
| WO-1995008639-A1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | NORTH AMERICAN SCIENCE ASSOCIATES, INC. (US) | 1995-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058288-A1 | Compound for use in the detection and prevention of parasitic infection of humans | CD4, OGA, GPI | MMP9 3744/4885MMP2 1576/4885ITGB3 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.